You are here

Clinical Trials: Heart Disease

Comment

Discuss

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Wednesday, March 8, 2017 - 20:00
Conditions:   Hypoplastic Left Heart Syndrome;   Atrioventricular Canal
Intervention:   Biological: MPC; rexlemestrocel-L
Sponsor:   Boston Children’s Hospital
Not yet recruiting - verified March 2017
Posted: Sunday, February 12, 2017 - 20:00
Condition:   Quality of Life
Interventions:   Drug: Caduet 10Mg-20Mg Tablet;   Drug: NorvasC® 10 mg Tablets
Sponsor:   Kosin University Gospel Hospital
Not yet recruiting - verified February 2017
Posted: Tuesday, February 7, 2017 - 20:00
Conditions:   Myocardial Infarction;   Stem Cell Transplantation;   Angioplasty, Transluminal, Percutaneous Coronary
Interventions:   Drug: Atorvastatin;   Drug: Intensive Atorvastatin;   Drug: Low dose BMMSC;   Drug: Middle dose BMMSC;   Drug: High dose BMMSC;   Drug: Transplantation
Sponsors:   Yuejin Yang;   Peking Union Medical College Hospital;   The First Hospital of Hebei Medical University;   Zunyi Medical College
Not yet recruiting - verified February 2017
Posted: Wednesday, November 23, 2016 - 20:00
Conditions:   Endothelial Progenitor Cells;   Coronary Artery Disease;   Vascular Injury;   Coronary Angiography
Intervention:   Biological: Administration of radio labelled endothelial outgrowth cells
Sponsors:   University of Edinburgh;   British Heart Foundation
Recruiting - verified October 2016
Posted: Thursday, October 20, 2016 - 19:00
Conditions:   Foramen Ovale, Patent;   Heart Septal Defects, Atrial;   Atrial Septal Defect
Intervention:   Other: Blood samples
Sponsor:   University Hospitals of North Midlands NHS Trust
Recruiting - verified November 2016
Posted: Wednesday, October 19, 2016 - 19:00
Condition:   Acute Coronary Syndrome
Interventions:   Drug: Atorvastatin;   Other: Blood samples
Sponsor:   University Hospitals of North Midlands NHS Trust
Recruiting - verified November 2016
Posted: Monday, October 3, 2016 - 19:00
Condition:   Heart Failure With Normal Ejection Fraction
Interventions:   Biological: Cell Therapy;   Biological: Control Procedure
Sponsor:   University Medical Centre Ljubljana
Recruiting - verified October 2016
Posted: Wednesday, August 31, 2016 - 19:00
Condition:   Coronary Artery Disease
Interventions:   Drug: ticagrelor;   Drug: clopidogrel
Sponsor:   First Affiliated Hospital of Harbin Medical University
Recruiting - verified August 2016
Posted: Wednesday, August 10, 2016 - 19:00
Conditions:   Congestive Heart Failure;   Heart Failure, Diastolic
Interventions:   Biological: Allogenic Derived Cells;   Biological: Placebo/Control Arm
Sponsor:   Medical University of South Carolina
Recruiting - verified August 2016
Posted: Sunday, August 7, 2016 - 19:00
Condition:   Coronary Artery Disease
Intervention:   Biological: Transepicardial with Transseptal CD 133+ Implantation
Sponsor:   National Cardiovascular Center Harapan Kita Hospital Indonesia
Recruiting - verified August 2016

Pages